Código QR (código de barras bidimensional)

A Review of Trastuzumab Biosimilars in Early Breast Cancer and Real World Outcomes of Neoadjuvant MYL-1401O versus Reference Trastuzumab

The reduced cost of trastuzumab biosimilars has led to increased adoption for HER2-positive breast cancer. This review of trastuzumab biosimilars encompasses this development and real world clinical data in early breast cancer. In addition, we present a retrospective study evaluating the total patho...

Fuld beskrivelse

Na minha lista:
Principais autores: Charlie Yang, Raida Khwaja, Patricia Tang, Nancy Nixon, Karen King, Sasha Lupichuk
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2022-06-01
Serier:Current Oncology
Fag:
trastuzumab
biosimilar
MYL-1401O
HER2+
breast cancer
early stage
Online adgang:https://www.mdpi.com/1718-7729/29/6/337
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker